濮阳东方医院治早泄技术先进濮阳东方妇科技术安全放心,濮阳东方看男科病价格便宜,濮阳市东方医院治病好不好,濮阳东方男科很好,濮阳东方在哪个位置,濮阳东方医院看早泄很不错,濮阳东方医院男科治阳痿口碑评价很好

BEIJING, Jan. 20 (Xinhua) -- China will regulate the production and sale of cosmetic colored contact lenses by including them in its list of items classified as "medical apparatus."Some people wear such non-corrective colored contacts to change or enhance eye color for cosmetic and fashion purposes.As these contacts are not for vision correction and medication purposes, they are currently off limits to the country's medical administration and regulators, said a statement published on the website of the State Food and Drug Administration on Thursday.However, with the increasingly popular use of cosmetic contacts, safety and quality problems due to the regulation loophole are likely to harm consumers' health, and the administration has decided to expand the current medical regulation on contact lenses to cover cosmetic ones, the statement said.It explained that the administration will soon issue a notice to ban the manufacture and sale of these contacts without proper registration and licenses.The statement also warned consumers of the risks of these contacts and suggested they carefully choose and use such products.

BEIJING, Oct. 11 (Xinhuanet) -- For women, chocolate consumption needs to be high, which can lower stroke risk, researchers from the Karolinska Institute, Sweden, reported in the Journal of the American College of Cardiology. The consumption of chocolate has been demonstrated to reduce diastolic and systolic blood pressure in randomized, short-term trials. Chocolate has also been shown to improve endothelial and platelet function, and to improve insulin resistance.Susanna Larsson Ph.D. and the team conducted the research on the Swedish Mammography Cohort's 33,372 adult females aged from 49 to 83 years without history of stroke, coronary heart disease, stroke, or diabetes.They found those who ate at least two chocolate bars each week appeared to have a 20 percent lower risk of stroke, compared to those of the same age and weight who rarely or never ate chocolate. But, they found, it was only those in the highest quartile of chocolate consumption who had a significant drop in stroke risk.The researchers explained that cocoa has flavonoids - powerful antioxidants that can suppress LDL, low-density lipoprotein, that can cause stroke and other cardiovascular diseases.

BEIJING, Dec. 30 (Xinhua) -- Chinese State Councilor Dai Bingguo and U.S. National Security Advisor Tom Donilon held a telephone conversation on China-U.S. relations on Friday.The two senior officials reviewed recent developments in China-U.S. relations and agreed to carry out in 2012 the important consensus reached between the heads of state of the two countries.They also pledged to strengthen dialogue, mutual trust and cooperation, properly handle disputes, and promote a healthy and steady development of China-U.S. relations.Dai and Donilon also exchanged views on other issues of common concern.

TEHRAN, Dec. 8 (Xinhua) -- Iranian inventors ranked first in the Seoul International Invention Fair (SIIF) in South Korea, the official IRNA news agency reported on Thursday.The three-member Iranian team from Tabriz city of Iran's northwestern East Azerbaijan province was ranked first by winning one gold and one silver medals in the fields of development and environment, said the report.South Korea, the United States and Chinese Taipei were selected as other three top teams after Iran.The Seoul International Invention Fair was held in the COEX Korea Exhibition Center from December 1 to 4, at which Some 700 participants from 32 countries and regions took part.

WASHINGTON, Jan. 19 (Xinhua) -- New research published this week in Nature Medicine indicates that targeted drugs such as gefitinib might more effectively treat non-small cell lung cancer if they could be combined with agents that block certain microRNAs.The study, led by investigators with the Ohio State University Comprehensive Cancer Center, shows that overexpression of two genes called MET and EGFR causes the deregulation of six microRNAs, and that this deregulation leads to gefitinib resistance.The findings support the development of agents that restore the levels of these microRNAs. It offers a new strategy for treating non-small cell lung cancer, which is responsible for about 85 percent of the 221,000 lung-cancer cases and 157,000 deaths that occur annually in the United States. It also suggests that measuring the expression levels of certain microRNAs -- those controlled by the MET gene -- might predict which lung-cancer cases are likely to be resistant to gefitinib.Epidermal growth factor receptor (EGFR) is frequently overexpressed in non-small cell lung cancer, and this leads to uncontrolled cell proliferation. Gefitinib selectively inhibits EGFR activation and triggers cancer cells to self-destruct by apoptosis. However, non-small cell lung cancer cells inevitably develop resistance to the drug. The study reveals how this resistance occurs."Our findings suggest that gefitinib resistance that is caused by MET overexpression is at least partly due to miRNA deregulation, " says principal investigator Carlo Croce.